New York Times cites UC research in story about second-and thirdhand smoke
Health columnist Jane E. Brody quotes University of Cincinnati professors as she makes the case that parents should keep their children out of places smoking is permitted
Research penned by University of Cincinnati faculty members inspired The New York Times personal health columnist Jane E. Brody to write about the ongoing threat posed by second- and thirdhand smoke to the health of children exposed to them.
In "The Risks to Children From Adults Who Smoke," Brody makes the case that children should be kept away from places where smoking is permitted, even if no one is smoking at a given time.
"Wise parents should keep their children out of any environment where smoking is allowed, even if no one is smoking there at the time," Brody writes. "The reason? Growing concern about the potential harms caused by exposure to the nicotine and other tobacco toxicants in thirdhand smoke that linger in the environment long after the smoke is gone."
Brody's argument relies on published research by UC faculty members about the effects of chronic tobacco exposure on children in both the short and long term. First she cites the work of Dr. E. Melinda Mahabee-Gittens and colleagues at UC, published in March 2017 in Tobacco Control. Mahabee-Gittens and company discovered that the residue from secondhand smoke accumulates on smokers and the surfaces in the vicinity of where they smoke, and that those toxicants can easily get on children's hands and into their bodies.
She also quotes human services professor Ashley L. Merianos, whose research published recently in Pediatrics finds that as little as one hour of exposure to secondhand smoke per week can have a significant impact on the health of adolescents.
Brody is among the most prominent health writers in the world, having served in her role as personal health columnist for The New York Times since 1976. Her widely read column appears in The Times' Science Times section and in numerous newspapers across the country.
A research powerhouse
The University of Cincinnati is classified as a Research I institution by the Carnegie Commission, and is ranked in the National Science Foundation's top 35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Learn more about advanced degrees at UC.
Related Stories
Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.
Travel, tattoos & vaccine truths: Clearing up blood donation myths
February 3, 2026
In recent years, the U.S. Food and Drug Administration (FDA) has updated several blood donation deferrals and restrictions. Despite these changes, many myths and misconceptions persist about who can and cannot donate safely.
UC study: New treatment guidelines needed for chronic kidney disease patients
February 3, 2026
A recently published study from the University of Cincinnati College of Medicine emphasizes the need for new treatment guidelines in the U.S. on reproductive health among patients with chronic kidney disease (CKD).
Alpaugh family legacy continues
February 3, 2026
A $10 million estate gift from the Alpaugh Foundation will support the Alpaugh Family Economics Center at the University of Cincinnati, continuing the extraordinary legacy the Alpaugh family began half a century ago.
Cancer Center tests treatment using ‘glioblastoma-on-a-chip’ and wafer technology
February 3, 2026
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.
University of Cincinnati gets $1.1M for AI physician training
January 30, 2026
The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.